An out-of-specification result was obtained in long-term stability testing for the parameter: aripiprazole active substance content, confirming that the product does not meet quality requirements. Potential effects: lack of treatment efficacy or adverse effects related to an incorrect dose.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Aribit 30 mg from batch 011020 with expiry date 10.2023. Check the batch number on the packaging and, if you have this batch, return the product to a pharmacy and consult a doctor if in dou...
The Chief Pharmaceutical Inspector withdrew batch 011020 of Aribit 30 mg from the market throughout the country and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related